Clinical trial

A Pilot Study of the Treatment of Central Serous Chorioretinopathy With…

NCT00211393 · Manhattan Eye, Ear & Throat Hospital, Other · Completed

Key facts

NCT number NCT00211393
Title A Pilot Study of the Treatment of Central Serous Chorioretinopathy With Ketoconazole
Official title A Pilot Study of The Treatment of Central Serous Chorioretinopathy With Ketoconazole.
Acronym CSC/Keto
Lead sponsor Manhattan Eye, Ear & Throat Hospital, Other
Collaborators LuEsther T. Mertz Retinal Research Center
Status Completed
Phase Phase 2
Study type Interventional
Conditions Chronic Central Serous Chorioretinopathy
Intervention type Drug
Interventions ketoconazole
Enrollment 5
Start date May 1, 2005
Primary completion Mar 1, 2008
Completion Apr 1, 2008
First posted Sep 21, 2005
Last update posted Oct 25, 2012
Countries United States

At a glance

  • 1–9 Study sites
  • No Results posted
  • None Linked FDA submissions

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About ClinicalTrials.gov studies

ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.

Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date:

Browse all ClinicalTrials.gov studies